Does Ph+ in AML exist or not? vs CML

ESH eLearning, Catherine Smith, 349594

Discussion

ESH eLearning, Faculty / Presenters, 348394

The role of CAR T-cell therapy in cancer in 2030

ESH eLearning, Carl June, 348393

Introduction

ESH eLearning, Faculty / Presenters, 348392

Panel discussion

ESH eLearning, Faculty / Presenters, 348391

Perspectives: T-cell Non-Hodgkin’s Lymphoma

ESH eLearning, Paul Maciocia, 348390

Perspectives: Mantle Cell Lymphoma and Follicular Lymphoma

ESH eLearning, Marie José Kersten, 348389

Panel discussion

ESH eLearning, Faculty / Presenters, 348388

Case-based lecture: CAR-T for bridging to allogeneic transplant or repeated CARs?

ESH eLearning, Sara Ghorashian, 348387

Case-based lecture: CAR-T after allogeneic transplant

ESH eLearning, André Baruchel, 348386

Case-based lecture: CAR T-cell therapy in childhood ALL: what can we learn for adult patients?

ESH eLearning, Peter Bader, 348385

Discussion

ESH eLearning, Faculty / Presenters, 348384

CAR T-cells

ESH eLearning, Marie José Kersten, 348383

Bispecific antibodies

ESH eLearning, Martin Hutchings, 348382

Allo-transplant

ESH eLearning, Bertram Glass, 348381

Introduction

ESH eLearning, John Gribben, 348380

Panel discussion

ESH eLearning, Faculty / Presenters, 348379

Case-based lecture: Bispecifics in first line DLBCL?

ESH eLearning, Richard Greil, 348378

Case-based lecture: Bispecifics in relapsed DLBCL?

ESH eLearning, Stephan Schuster, 348377

Short Oral Presentation: Antitumor Activity and Safety Profile of Subcutaneous Epcoritamab in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Dose-Escalation Data from the Epcore NHL-1 Trial

ESH eLearning, Pieternella (Elly) Lugtenburg, 348376

Interactive case

ESH eLearning, Marion Subklewe, 348375

Live discussion

ESH eLearning, Faculty / Presenters, 348374

ESH eLearning, Faculty / Presenters, 348373

Discussion

ESH eLearning, Faculty / Presenters, 348372

CARs

ESH eLearning, Sham Mailankody, 348371

Bispecific antibodies

ESH eLearning, Hermann Einsele, 348370

Introduction

ESH eLearning, María-Victoria Mateos, 348369

Panel discussion

ESH eLearning, Faculty / Presenters, 348368

Interactive case: Multiple Myeloma

ESH eLearning, María-Victoria Mateos, 348367

Short Oral Presentation: Teclistamab and Talquetamab Modulate Levels of Soluble B-Cell Maturation Antigen in Patients with Relapsed and/or Refractory Multiple Myeloma

ESH eLearning, Suzette Girgis, 348366

Short Oral Presentation: Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy, in Relapsed/Refractory Multiple Myeloma (R/R MM): Updated Results from Cartitude-1

ESH eLearning, Saad Z. Usmani, 348365

Case-based lecture: BCMA targeted CAR T-cell therapy for multiple r/r MM

ESH eLearning, Sham Mailankody, 348364

Short Oral Presentation: Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) × CD3 Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results of a Phase 1, First-in-Human Study

ESH eLearning, Niels W.C.J. van de Donk, 348363

Interactive case: Multiple Myeloma

ESH eLearning, María-Victoria Mateos, 348362

Panel discussion

ESH eLearning, Faculty / Presenters, 348361

Perspectives: Learning from doing?

ESH eLearning, Christian Chabannon, 348360

Case-based lecture: Hematotoxicity: early & late Cytopenia and Hypogammaglobulinaemia

ESH eLearning, Marion Subklewe, 348359

Case-based lecture: Novel strategies to prevent/treat CRS/ICANS

ESH eLearning, Stephan Grupp, 348358

Interactive case: ICANS grading and management

ESH eLearning, Peter Schellongowski, 348357

Interactive case: CRS grading and management

ESH eLearning, Ulrich Jäger, 348356

Panel discussion

ESH eLearning, Faculty / Presenters, 348355

Perspectives: Ongoing clinical trials and developments in DLBCL

ESH eLearning, Gilles Salles, 348354

Short Oral Presentation: Longitudinal CAR T-Cell Detection and Quantification by Ddpcr in Cellular and Cell-Free DNA in Patients Treated with Tisagenlecleucel

ESH eLearning, Adrian Minson, 348353

Interactive case: Monitoring CAR expansion and persistence?

ESH eLearning, Peter Borchmann, 348352

Case-based lecture: Real world data: patient selection and bridging strategies?

ESH eLearning, Catherine Thieblemont, 348351

Panel Discussion

ESH eLearning, Faculty / Presenters, 348430

Ph-like ALL Patient Management

ESH eLearning, Sarah Tasian, 348429

Next generation TKIs for Ph+ ALL

ESH eLearning, Nicholas Short, 348428

Which TKI-Chemo-Transplant Cocktail for Ph+ ALL?

ESH eLearning, Yves Chalandon, 348427

Panel Discussion

ESH eLearning, Faculty / Presenters, 348426

Novel Therapies for T-ALL/LL

ESH eLearning, Anjali Advani, 348425

Should T-LL and T-ALLs be treated on the same protocols?

ESH eLearning, Elisabeth Macintyre, 348424

Risk Factors in T-ALL

ESH eLearning, Elizabeth Raetz, 348423

Keynote: Management of T-LL Patients

ESH eLearning, Dieter Hoelzer, 348422

Panel Discussion

ESH eLearning, Faculty / Presenters, 348421

Frontline Chemo-free Regimens in Ph+ ALL

ESH eLearning, Sabina Chiaretti, 348420

Panel Discussion

ESH eLearning, Faculty / Presenters, 348419

Post-transplant Interventions

ESH eLearning, David Marks, 348418

New CARs for B-cell Precursor ALL

ESH eLearning, Claire Roddie, 348417

Panel Discussion

ESH eLearning, Faculty / Presenters, 348416

Selected brief oral communication: Oncogenic Cooperation between the TCF7-SPI1 fusion and NRAS(G12D) Requires β-Catenin Activity to Drive T-Cell Acute Lymphoblastic Leukemia

ESH eLearning, Quentin Van, 348415

Selected brief oral communication: Pharmacologic Inhibition of DYRK1A Results in Hyperphosphorylation of ERK and Consequently in Apoptosis of KMT2A-Rearranged ALL

ESH eLearning, Christian Hurtz, 348414

New ALL Drugs

ESH eLearning, Matthew J. Wieduwilt, 348413

TKI Use in Ph+/Ph-like Diseases

ESH eLearning, Stephen P. Hunger, 348412

The Critical Role of Microenvironment in ALL

ESH eLearning, Adele K. Fielding, 348411

Panel Discussion

ESH eLearning, Faculty / Presenters, 348410

Selected brief oral communication: T(1;19)(q23;p13) TCF3-PBX1 May Not be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated with MRD-Oriented Protocols from the Pethema Group

ESH eLearning, Jordi Ribera, 348409

Management of Relapsed ALL

ESH eLearning, Elias Jabbour, 348408

Treatment Issues in Teenagers and Young Adults ALL

ESH eLearning, Rachael Hough, 348407

Panel Discussion

ESH eLearning, Faculty / Presenters, 348406

IG-TCR versus BCR-ABL1 MRD in Ph+ ALL

ESH eLearning, Jan Zuna, 348405

Panel Discussion

ESH eLearning, Faculty / Presenters, 348404

Targeting CD3 in T-ALL

ESH eLearning, Jacques Ghysdael, 348403

Aberrant Signaling in T-cell ALL

ESH eLearning, Jan Cools, 348402

Molecular Mechanisms of T-ALL

ESH eLearning, Adolfo Ferrando, 348401

Panel Discussion

ESH eLearning, Faculty / Presenters, 348400

Selected brief oral communication: Mechanistic Basis for Targeting BCL6 in RAS-Driven B-Cell Acute Lymphoblastic Leukemia

ESH eLearning, Lai Chan, 348399

Targeting Novel B-cell progenitor ALL Subtypes

ESH eLearning, Charles Mullighan, 348398

Myeloid Switch of B-cell Precursor ALL Subtypes

ESH eLearning, Ester Mejstrikova, 348397

Transcriptional Landscape of B-cell Precursor ALL

ESH eLearning, Henrik Lilljebjörn, 348396

Keynote: HOX Gene Deregulation in ALL

ESH eLearning, Scott Armstrong, 348395

Discussion

ESH eLearning, Faculty / Presenters, 336538

The future is now, science fiction thereafter

ESH eLearning, Francesca Gay, 336537

There is no future without past

ESH eLearning, Kenneth C. Anderson, 336536

Case-based lecture: How I treat amyloidosis

ESH eLearning, GIAMPAOLO MERLINI, 336531

Brief Oral Communication - Reductions in Absolute Iflc and Dflc Are Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Vcd with or without Daratumumab: Results from Andromeda

ESH eLearning, Faculty / Presenters, 336534

Case-based lecture: How to treat bone disease in multiple myeloma

ESH eLearning, Elena Zamagni, 336533

Panel discussion

ESH eLearning, Faculty / Presenters, 336535

Case-based lecture: How I treat MGRS and MGUS with neuropathy

ESH eLearning, Stefan Knop, 336532

Case-based lecture : Antibody based immunotherapy

ESH eLearning, Niels W.C.J. van de Donk, 336526

Interactive case: Bi- and trispecific antibodies in multiple myeloma

ESH eLearning, Hermann Einsele, 336524

Case-based lecture : CART in multiple myeloma

ESH eLearning, Nina Shah, 336525

Case-based lecture : Future immunotherapies in multiple myeloma

ESH eLearning, Eric Smith, 336527

Brief Oral Communication - Cartitude-1, a Phase 1b/2 Study of Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma (RRMM)

ESH eLearning, Deepu Madduri, 336528

Brief Oral Communication - Teclistamab, a B-Cell Maturation Antigen (BCMA) X CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Phase 1 Results

ESH eLearning, Faculty / Presenters, 336529

Panel discussion

ESH eLearning, Faculty / Presenters, 336530

Multiple Myeloma Research Foundation

ESH eLearning, Daniel Auclair, 336522

Access to drugs in Europe

ESH eLearning, Jean-Luc Harousseau, 336523

Food and Drug Administration

ESH eLearning, Bindu Kanapuru, 336521

Discussion

ESH eLearning, Faculty / Presenters, 336520